# Delayed Versus Early Antihyperglycemic Treatment for Severe Stroke

Study · id `cardio:ct-nct07501533` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07501533](<https://clinicaltrials.gov/study/NCT07501533>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07501533

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 200 participants.

## Technical summary

Registry record NCT07501533. Randomized; no masking; primary purpose treatment. Start 2026-06-18 (actual); primary completion 2028-03-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT07501533, source copy `cardio:ctgov-nct07501533-2026-09-04`, retrieved 2026-10-26)
- Started: 2026-06-18 (actual) (ClinicalTrials.gov record NCT07501533, source copy `cardio:ctgov-nct07501533-2026-09-04`, retrieved 2026-10-26)
- Primary completion: 2028-03-31 (anticipated) (ClinicalTrials.gov record NCT07501533, source copy `cardio:ctgov-nct07501533-2026-09-04`, retrieved 2026-10-26)
- Completion: 2028-03-31 (anticipated) (ClinicalTrials.gov record NCT07501533, source copy `cardio:ctgov-nct07501533-2026-09-04`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT07501533, source copy `cardio:ctgov-nct07501533-2026-09-04`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07501533-2026-09-04`, retrieved 2026-10-26)

## The registry's words

- Brief title: Delayed Versus Early Antihyperglycemic Treatment for Severe Stroke
- Condition: Severe Stroke
- Intervention (Drug): Intravenous insulin
- Lead sponsor: First Affiliated Hospital of Wannan Medical College
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: First Affiliated Hospital of Wannan Medical College (`cardio:org-first-affiliated-hospital-of-wannan-medical-college`)

## Provenance

Content hash: 8d9806610373f40aac9696c94f7e2dd82de5fc0901e3fd259b82a226c9bec24c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
